The Venture Collective has been named a 2026 Power100 Asset Managers honoree by Blueprint Capital Advisors, recognizing top-performing asset managers in venture capital.

X-Energy raised roughly $1 billion in its Nasdaq IPO (ticker “XE”), pricing well above its initial range as investors back small modular reactor technology to meet surging AI and data center energy demand.

Mimikai has launched the first new EPA-approved repellent active ingredient in 25 years — undecanone, derived from wild tomatoes — matching DEET’s effectiveness and selling out within two weeks of its retail debut.

Life Biosciences closed an $80 million Series D to fund operations through 2027, including completing its Phase 1 trial of ER-100 for optic neuropathies and advancing its Partial Epigenetic Reprogramming platform.

SimpliFed raised $10.8 million to expand its virtual, comprehensive maternal and infant feeding care platform for new parents.

Backed by a $60 million STRATFI contract from the U.S. Space Force, Gravitics will flight-test its Orbital Carrier pathfinder and a Viper OTX vehicle, pre-positioning maneuverable spacecraft in orbit for rapid, on-demand in-space operations.

Cocoon raised $15 million in Series A funding to scale LoopCem™, its low-carbon cement replacement made from steel-mill by-products that cuts embodied CO₂ by up to 27% without added cost or performance trade-offs.

Unnatural Products raised $45 million to advance its machine-learning-driven macrocyclic peptide portfolio toward the clinic.

Unnatural Products signed a licensing agreement with Novartis worth up to $1.7 billion to develop a cardiovascular program built on its macrocyclic peptide platform.

Wizard Wellness has launched a drug-free allergy and nasal care brand built on its proprietary Nasalbiome™ technology, bringing a fresh, design-led approach to allergy care.

Gravitics was selected as an awardee under the Missile Defense Agency’s SHIELD program, an IDIQ contract supporting rapid delivery of defense capabilities and complementing its Orbital Carrier work.

Procter & Gamble has acquired Wonderbelly, the Austin-based maker of clean-label digestive health products — antacids and bloat relief free from artificial dyes, titanium dioxide, and sweeteners.

Orbem raised €55.5 million in Series B funding led by Innovation Industries and Supernova Invest to expand into the U.S., launch new solutions for the poultry industry, and enter the fruit and vegetable market.

Lyric Bio closed $6.6 million in seed financing to advance its tissue-engineered bioreactors for producing donor-independent human biologics at scale.

Mach secured $7 million in funding and announced OEM partnerships with Amazone, Dok-Ing, and Alamo Group to bring its full-stack autonomy solutions — navigation, vision, radar, and fleet management — to off-road equipment across agriculture and defense.

Fork & Good has acquired Orbillion Bio to merge their B2B-cultivated-meat platforms, combining Fork & Good's pork focus with Orbillion's beef expertise, expanding into Europe and the Middle East, and forming one of the largest IP portfolios in the industry.

MDisrupt accelerates healthcare startup growth by connecting founders with leading medical experts who provide strategic guidance, clinical credibility, and faster market access.

Caravel Bio is launching the first unified platform for protein discovery and delivery, combining cell-free synthesis, bacterial spore display, and machine learning to develop novel protein chemistries for DNA synthesis, animal health and sustainable manufacturing.

Argenx struck a deal worth $1.5B with Unnatural Products to develop macrocyclic peptide drugs for “undruggable” protein targets. UNP will handle early R&D, while argenx can take successful candidates to market. The deal includes milestones, royalties, and an equity investment.

Siemens is partnering with Entocycle to digitally transform insect-farming by using digital-twin modelling, AI and automation to scale the conversion of food waste into sustainable protein while cutting larval growth time and boosting survival rates by around 30%

Summer Health has acquired Caraway Health, a platform specializing in care for Gen Z. This strategic acquisition marks a milestone at Summer Health to raise the healthiest generation.

Our firm is grateful to be honored alongside some of the best in the business. Thank you to Power100 Presented By Blueprint Capital Advisors LLC for the recognition.

Shizu Okusa has been recognized by Inc. as one of the 500 Female Founders to watch in 2025.

X-energy, a company aiming to develop high-tech nuclear plants, said on Thursday it has closed $700 million in financing to help finish reactor design and licensing as well as construction of a fuel-making facility.

Maternal Health-Focused Telehealth Company Furthers Mission with the Support of Morningside, The Venture Collective, Empire State Development, The Artemis Fund, Cultivation Capital, AHA Ventures, and Existing Investors

In this episode of How I Invest, David Weisburd sits down with Nick Shekerdemian, entrepreneur, investor, and founding partner of The Venture Collective (TVC). A former Oxford student turned Thiel Fellow, Nick shares his journey of dropping out of university to pursue big ideas and how the fellowship helped shape his path in venture capital.

In a move to distinguish itself in the crowded market, Ollie, the “human grade” pet food subscription service, is venturing into a new territory: AI-powered pet diagnostics. The company announced on Thursday its acquisition of DIG Labs for an undisclosed sum, a pet health tech startup that touts its proprietary dog stool image scanning and analysis capabilities.

Excelling in the Private Equity & Venture Capital industry requires deep knowledge and awareness of current trends…At Wealth & Finance International, we believe that those firms who are still performing at a high level should be celebrated. To remain persistent and successful in an increasingly uncertain industry is as impressive as it is admirable!

Gina Shekerdemian, co-founder of The Venture Collective, has been recognized among the top 60 women-led venture capital leaders.

Months after hailing macrocyclic peptides as the “next wave of drug discovery,” Merck & Co. has pushed further into the space by penning a $220 million biobucks deal with Unnatural Products.

Excelling in the Private Equity & Venture Capital industry requires deep knowledge and awareness of current trends…At Wealth & Finance International, we believe that those firms who are still performing at a high level should be celebrated. To remain persistent and successful in an increasingly uncertain industry is as impressive as it is admirable!

Solving wicked problems—complex interconnected societal challenges—used to be the province of government and philanthropists. Now startups are tackling challenges like climate change, access to healthcare, and equality.

If space stations are the next phase of business in orbit, they’re going to need standard parts — and Gravitics aims to be the one making them. The startup is headed by space industry veteran Colin Doughan, who surveyed these currents and saw a gap in the market.

TVC invests in companies that apply transformative technologies and science to purpose-driven solutions. Nowhere do we see this play out more fruitfully than in our Industrial Transformation vertical, in which the pain point requires us to completely reimagine how we live in order to solve the most complex existential problem facing mankind.

TVC invests in companies that apply transformative technologies and science to purpose-driven solutions. Nowhere do we see this play out more fruitfully than in our Industrial Transformation vertical, in which the pain point requires us to completely reimagine how we live in order to solve the most complex existential problem facing mankind.

While working at Oscar Health, Gaurang Choksi realized a disconnect when it came to the inclusive care that diverse patients needed. He remembers that clients would come in looking for a health care clinician that represented them, but that wasn’t a possibility.

If the world wants to feed 10 billion people in 2050, it’ll need to find a better way to grow food. Today, about half the world’s habitable land is devoted to agriculture, yet even that amount can’t provide everyone with the sort of diet enjoyed by people in developed countries.

The funding round was led by Morningside Ventures and The Venture Collective, with participation from NY Ventures, Elizabeth Street Ventures, Waterline Ventures and 3CC.

Ellevest, the financial company built by women for women, today a $53M funding round. The round was co-led by BMO and Contour Venture Partners.

Axiom is proud to share our vision of a thriving home in space that benefits every human, everywhere as we continue to expand the low Earth orbit economy with missions to the International Space Station and the progressing construction of Axiom Station, the next-gen platform for innovation and breakthroughs.

This may not come as a surprise — commercialism is alive and well– but the fact that the equivalent of one garbage truck full of clothes is burned or dumped in a landfill every second may give you pause.

Development of the world's first fully reusable horizontal takeoff and landing, single-stage to orbit spaceplane takes critical step forward with investment.

Senior management and founders invested in the Series C financing alongside longevity-oriented funds, seasoned investors, and experienced biotechnology scientists/entrepreneurs. Since its founding, Life Biosciences has raised over $158 million.